Trial Profile
Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Jul 2018
Price :
$35
*
At a glance
- Drugs Droxidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 20 Jun 2018 Status changed from recruiting to completed.
- 06 Jun 2017 New trial record